If youre losing weight at a sustainable rate, tolerating the side effects, and building habits alongside the medication, theres little reason to switch
PR Newswire / Eli Lilly press release (TRANSCEND-T2D-1 topline) (2026) 8
If approved by insurance, the monthly cost for Zepbound could drop to as little as $25, significantly impacting out-of-pocket expenses for patients
PlexusDx's Precision Peptide Genetic Test examines key variants in GLP1R, GIPR, FTO, and MC4R genes that relate to appetite regulation and GLP-1 signaling
No state-licensing verification, prescribing without evaluation, no follow-up, vague pricing or sourcing, and exaggerated promises
Quality control varies wildly between manufacturers